{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:03:56Z","timestamp":1792494236960,"version":"4.5.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Stroke"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:p>Antibodies directed at the amyloid-\u03b2 peptide offer the prospect of disease-modifying therapy for early-stage Alzheimer disease but also carry the risk of brain edema or bleeding events, collectively designated amyloid-related imaging abnormalities. Introduction of the antiamyloid immunotherapies into practice is therefore likely to present a new set of questions for clinicians treating patients with cerebrovascular disease: Which manifestations of cerebrovascular disease should preclude, or permit, antibody treatment? Is it safe to prescribe amyloid immunotherapies to individuals who require antithrombotic treatment, or to administer thrombolysis to antibody-treated individuals with acute stroke? How should severe amyloid-related imaging abnormalities be managed? This science advisory summarizes the data and key considerations to guide these challenging decisions as the medical community collects further data and experience with these groundbreaking agents.<\/jats:p>","DOI":"10.1161\/str.0000000000000480","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T05:07:16Z","timestamp":1733893636000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":50,"title":["Vascular Neurology Considerations for Antiamyloid Immunotherapy: A Science Advisory From the American Heart Association"],"prefix":"10.1161","volume":"56","author":[{"given":"Steven M.","family":"Greenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo J.","family":"Aparicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Furie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu S.","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Hinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariel","family":"Kozberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2022.30"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2212948"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.13239"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26511"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2023.30"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2215148"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43933-5"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad188"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.22.28461"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2021.4161"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12377"},{"key":"e_1_3_1_13_2","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1212\/WNL.0000000000205071","article-title":"ARIA insights from the donanemab trials.","volume":"102","author":"Greenberg SM","year":"2024","unstructured":"Greenberg SM, Battioui C, Lu M, Biffi A, Ardayfio P, Zimmer JA, Evans CD, Wang H, Monkul Nery ES, Sparks J, et al. ARIA insights from the donanemab trials. Neurology. 2024;102(17 Suppl 1):P1\u20139.001.","journal-title":"Neurology"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01441-8"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2015.4078"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23857"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-022-01124-2"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awn261"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00208-3"},{"key":"e_1_3_1_20_2","unstructured":"Food and Drug Administration. Aducanumab. Accessed October 7 2024. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/761178s011lbl.pdf"},{"key":"e_1_3_1_21_2","unstructured":"Food and Drug Administration. Lecanemab. Accessed October 7 2024. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/761269Orig1s000lbl.pdf"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2022.34"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2021.41"},{"key":"e_1_3_1_24_2","unstructured":"Food and Drug Administration. Donanemab. Accessed October 7 2024. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/761248s000lbl.pdf"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70013-4"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207919"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2014.681"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.120.032550"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.117.005795"},{"key":"e_1_3_1_30_2","unstructured":"Peripheral and Central Nervous System Drugs Advisory Committee. Donanemab for the treatment of patients with early symptomatic Alzheimer\u2019s disease: sponsor briefing document. Accessed October 7 2024. https:\/\/www.fda.gov\/media\/179167\/download"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.2991"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-024-12205-7"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.1782"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000407"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2308440"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.3171\/2024.1.jns231852"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.10082"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000010017"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000065"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.0000000000000046"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000375"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12474"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.149.2.351"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.32.6.1318"}],"container-title":["Stroke"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/STR.0000000000000480","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T13:23:43Z","timestamp":1745501023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/STR.0000000000000480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1161\/STR.0000000000000480"],"URL":"https:\/\/doi.org\/10.1161\/str.0000000000000480","relation":{},"ISSN":["0039-2499","1524-4628"],"issn-type":[{"value":"0039-2499","type":"print"},{"value":"1524-4628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"2024-12-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}